8YG-27828-36359
2 vaccinations
7 coded responses
8 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 152 / PA
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Pfizer-BioNTech
-
2021-04-19
Survey response — day 7, dose 1MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion, Sluggishness, Taste disorder — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaFree text: I am late reporting symptoms. Chest congestion, cough, sluggish body movement and slight lessening of taste.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
-
2021-05-01
Dose 2 — Pfizer-BioNTech
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Difficult to concentrateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain, Disturbance in attention — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painFree text: Pronounced Lack of concentration and chest painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Survey response — days 1–6 daily, dose 2MedDRA: Chest pain, Disturbance in attention, Vertigo, Vision blurred — Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal painFree text: Vertigo, blurred vision, chest pain, difficulty concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Temperature intolerance — Feeling: Fair · Chills, Headache, Fatigue or tiredness, Nausea, Abdominal painFree text: Erratic body tempsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — day 14, dose 2MedDRA: Disturbance in attention, Fatigue, Pain, Taste disorder — Feeling: FairFree text: After first vaccination, taste affected. Still not normal 2 weeks after 2nd vaccination. Fatigue and body aches continue as well as lagging concentration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-30
Survey response — 6 months, dose 2MedDRA: Ageusia, Dyspepsia, Dyspnoea, Fatigue, Insomnia — Feeling: FairFree text: Fatigue and shortness of breath slowly worsening, difficult digestion, partial loss of taste, difficulty sleeping.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech |
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): I am late reporting symptoms. Chest congestion, cough, sluggish body movement and slight lessening of taste.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Difficult to concentrate
Systemic reaction (other): Pronounced Lack of concentration and chest pain
Systemic reaction (other): Vertigo, blurred vision, chest pain, difficulty concentrating
Systemic reaction (other): Erratic body temps
Release 8 — day 14, dose 2
Symptoms: After first vaccination, taste affected. Still not normal 2 weeks after 2nd vaccination. Fatigue and body aches continue as well as lagging concentration.
Release 10 — 6 months, dose 2
Symptoms: Fatigue and shortness of breath slowly worsening, difficult digestion, partial loss of taste, difficulty sleeping.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Dyspepsia | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Taste disorder | ✓ | ✓ | ✓ |
| SRO | Chest pain | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Sluggishness | ✓ | ✓ | ✓ |
| SRO | Taste disorder | ✓ | ✓ | ✓ |
| SRO | Temperature intolerance | ✓ | ✓ | ✓ |
| SRO | Vertigo | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release